Kovachev T B, Stamberov P N, Ivanov D S, Mitcheva M K, Marinova S P, Astroug H A, Stoychkov J N
Higher Medical Institute, Faculty of Pharmacy, Department of Chemistry, Sofia, Bulgaria.
Pharmazie. 1994 Jan;49(1):25-7.
Co(II), Ni(II), Cu(II) and Zn(II) complexes of levamisole (LMS) were prepared and characterized by elemental analyses, IR spectroscopy, 1H and 13C NMR and mass spectrometry. The following general formula was derived: M(LMS)2Cl2, where M = Co, Ni, Cu, Zn. It was established that LMS behaved as a monodentate ligand and the coordination was accomplished through the N-7 atom. The toxicity and the immunomodulating activity of the complexes on mice and rats in comparison with uncomplexed LMS was assayed. The metals in the complexes exerted different changes in the toxicity of LMS. The complex containing Zn(II) was less toxic and manifested higher immunomodulating activity than LMS.
制备了左旋咪唑(LMS)的钴(II)、镍(II)、铜(II)和锌(II)配合物,并通过元素分析、红外光谱、1H和13C核磁共振以及质谱对其进行了表征。推导得到以下通式:M(LMS)2Cl2,其中M = Co、Ni、Cu、Zn。已确定LMS表现为单齿配体,配位通过N-7原子完成。测定了这些配合物与未配位的LMS相比对小鼠和大鼠的毒性及免疫调节活性。配合物中的金属对LMS的毒性产生了不同的变化。含锌(II)的配合物毒性较小,且表现出比LMS更高的免疫调节活性。